Literature DB >> 3583640

The activity of flavone acetic acid (NSC 347512) on human colon cancer cells in vitro.

B Drewinko, L Y Yang.   

Abstract

Flavone acetic acid (FAA) was incubated for 1 to 48 hr with 3 established human colon cancer cell lines endowed with distinct degrees of phenotypic properties. All 3 lines responded to FAA in almost identical fashion; when incubated with the drug for only 1 hr, an initial decrease in survival was observed for concentrations of 250 micrograms/ml but no further increments in cytotoxicity were elicited when the concentration of FAA was augmented. Increasing the length of treatment yielded relatively modest increments (about 1 log) in cell killing only after an interval of 48 hr and only at the highest concentration (1000 micrograms/ml). Because of these relatively poor cytotoxic effects and because the therapeutic range of FAA is so narrow, we conclude that this agent will not be a valuable contribution to the antitumor arsenal, at least for colon cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3583640     DOI: 10.1007/bf00173501

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  9 in total

1.  Comparison of in vitro methods to determine drug-induced cell lethality.

Authors:  P R Roper; B Drewinko
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

2.  Recent results of clinical therapeutic trials for gastrointestinal malignancies conducted in the United States.

Authors:  D L Kisner; P S Schein; J S Macdonald
Journal:  Recent Results Cancer Res       Date:  1981

3.  Patterns of cell survival following treatment with antitumor agents in vitro.

Authors:  B Drewinko; P R Roper; B Barlogie
Journal:  Eur J Cancer       Date:  1979-01       Impact factor: 9.162

4.  Why do colon tumours respond poorly to chemotherapeutic agents?

Authors:  L M van Putten; E A Sluijter; T Smink; J H Mulder
Journal:  Recent Results Cancer Res       Date:  1981

5.  Cellular discriminants for a biological classification of human colon carcinoma.

Authors:  B Drewinko; L Y Yang; A Leibovitz; B Barlogie; D Lutz; B Jansson; J J Stragand; J M Trujillo
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  Growth kinetics of human colorectal carcinoma.

Authors:  D M Ota; B Drewinko
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

7.  Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.

Authors:  J Plowman; V L Narayanan; D Dykes; E Szarvasi; P Briet; O C Yoder; K D Paull
Journal:  Cancer Treat Rep       Date:  1986-05

8.  Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester).

Authors:  D J Kerr; S B Kaye; J Graham; J Cassidy; M Harding; A Setanoians; J C McGrath; W R Vezin; D Cunningham; G Forrest
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

9.  Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.

Authors:  B Drewinko; M Patchen; L Y Yang; B Barlogie
Journal:  Cancer Res       Date:  1981-06       Impact factor: 12.701

  9 in total
  2 in total

1.  Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.

Authors:  Minh Hien Pham; Hervé Rhinn; Nicolas Auzeil; Anne Regazzetti; Djamel Eddine Harami; Daniel Scherman; Guy G Chabot
Journal:  Drug Metab Lett       Date:  2011-04

2.  Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro.

Authors:  G G Chabot; M C Bissery; A Gouyette
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.